elacridar has been researched along with pf 573228 in 1 studies
Studies (elacridar) | Trials (elacridar) | Recent Studies (post-2010) (elacridar) | Studies (pf 573228) | Trials (pf 573228) | Recent Studies (post-2010) (pf 573228) |
---|---|---|---|---|---|
284 | 8 | 119 | 80 | 0 | 72 |
Protein | Taxonomy | elacridar (IC50) | pf 573228 (IC50) |
---|---|---|---|
Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.743 | |
G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.743 | |
Glycogen synthase kinase-3 beta | Homo sapiens (human) | 1 | |
Cyclin-dependent kinase 7 | Homo sapiens (human) | 0.5985 | |
Cyclin-H | Homo sapiens (human) | 1 | |
CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | 1 | |
Focal adhesion kinase 1 | Homo sapiens (human) | 0.0563 | |
Protein-tyrosine kinase 2-beta | Homo sapiens (human) | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
1 other study(ies) available for elacridar and pf 573228
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |